Abstract
This review describes the strategy for the development of multifunctional dendrimeric and hyperbranched polymers, collectively named dendritic polymers, aiming at their application as drug and gene delivery systems. Employing well-characterized and mainly commercially available dendritic polymers, the functionalization of these polymers is aimed at providing drug carriers of low toxicity, high encapsulating capacity, specificity to certain type of cells and transport ability through their membranes. Following a step-wise functionalization strategy of the starting dendritic polymers one has the option to prepare products that fulfill one or more of these requirements. In particular, in addition to polyvalency which is a common feature of the dendritic polymers, these carriers bearing a number of targeting ligands exhibit specificity to certain cells, another type of groups secures stability in biological milieu and prolonged circulation, while other moieties facilitate their transport through cell membranes. Furthermore, dendritic polymers applied for gene delivery should be or become cationic in the biological environment for the formation of complexes with the negatively charged genetic material.
Keywords: Dendrimers, hyperbranched polymers, dendritic polymers, nanocarriers, drug delivery system, gene delivery
Current Topics in Medicinal Chemistry
Title: Multifunctional Dendritic Drug Delivery Systems: Design, Synthesis, Controlled and Triggered Release
Volume: 8 Issue: 14
Author(s): Constantinos M. Paleos, Dimitris Tsiourvas, Zili Sideratou and Leto Tziveleka
Affiliation:
Keywords: Dendrimers, hyperbranched polymers, dendritic polymers, nanocarriers, drug delivery system, gene delivery
Abstract: This review describes the strategy for the development of multifunctional dendrimeric and hyperbranched polymers, collectively named dendritic polymers, aiming at their application as drug and gene delivery systems. Employing well-characterized and mainly commercially available dendritic polymers, the functionalization of these polymers is aimed at providing drug carriers of low toxicity, high encapsulating capacity, specificity to certain type of cells and transport ability through their membranes. Following a step-wise functionalization strategy of the starting dendritic polymers one has the option to prepare products that fulfill one or more of these requirements. In particular, in addition to polyvalency which is a common feature of the dendritic polymers, these carriers bearing a number of targeting ligands exhibit specificity to certain cells, another type of groups secures stability in biological milieu and prolonged circulation, while other moieties facilitate their transport through cell membranes. Furthermore, dendritic polymers applied for gene delivery should be or become cationic in the biological environment for the formation of complexes with the negatively charged genetic material.
Export Options
About this article
Cite this article as:
Paleos M. Constantinos, Tsiourvas Dimitris, Sideratou Zili and Tziveleka Leto, Multifunctional Dendritic Drug Delivery Systems: Design, Synthesis, Controlled and Triggered Release, Current Topics in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/156802608785848996
DOI https://dx.doi.org/10.2174/156802608785848996 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Current Molecular Pharmacology Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy Minor-Groove Binding Agents: Rational Design of Carboxamide Bond Isosteres
Current Topics in Medicinal Chemistry Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Recent Patents on the Baculovirus Systems
Recent Patents on Biotechnology Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review
Current Topics in Medicinal Chemistry Mesothelioma - Epidemiology and Management
Current Respiratory Medicine Reviews Immunotherapy in Breast Cancer- Paving New Roads?
Current Molecular Pharmacology A Short Course on Virology / Vectorology / Gene Therapy
Current Gene Therapy P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry miRNAs in Alzheimer Disease – A Therapeutic Perspective
Current Alzheimer Research 5-Fluorouracil Derivatives Induce Differentiation Mediated by Tubulin and HLA Class I Modulation
Medicinal Chemistry Thioguanine, Mercaptopurine: Their Analogs and Nucleosides as Antimetabolites
Current Pharmaceutical Design Targeting the Assembly of the Human Immunodeficiency Virus Type I
Current Pharmaceutical Design Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication
Anti-Cancer Agents in Medicinal Chemistry Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells
Current Drug Targets The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets